Beranda › Kondisi Pasca-COVID (Long COVID) › Maryland
Uji klinis Kondisi Pasca-COVID (Long COVID) di Maryland
21 studi untuk Kondisi Pasca-COVID (Long COVID) mencari peserta di lokasi di Maryland.
Kota di Maryland
Teks studi resmi (Bahasa Inggris)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Annapolis Internal Medicine - CCT Research ( Site 3700), Annapolis
- Kur Research - Columbia Medical ( Site 3767), Columbia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06667700A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06577467Viral Infections in Healthy and Immunocompromised Hosts
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
6 Months – 120 Years · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT01306084Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT04573062Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
- Niaid/Lcim, Rockville
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 99 Years · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT04582903PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06920628Respiratory Virus Sampling and Repository
- National Institutes of Health Clinical Center, Bethesda
- NIH Building 33 (NIAID), Bethesda
Menerima pesertaStudi observasional
Usia 3 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05266222Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
- University of Maryland, Baltimore, Baltimore
Menerima peserta
Usia 50 hingga 94 · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT05977179Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Menerima pesertaSukarelawan sehat diterima
Hingga usia 80 · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT05880108The Impact of COVID-19 on Maternal and Neonatal Outcomes
- Johns Hopkins Hospital, Baltimore
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 14 hingga 55 · Wanita · Diperbarui 11 Mei 2026 · NCT05197621T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
- The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore
Menerima pesertaFase 1
Usia 2 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT05141058Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
- Kennedy Krieger Institute, Baltimore
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 12 Des 2025 · NCT07278388Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
- Johns Hopkins University, Baltimore
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Nov 2025 · NCT06128928Home-Based Exercise Tele-Rehabilitation After COVID-19
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Menerima pesertaSukarelawan sehat diterima
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 10 Nov 2025 · NCT05425264EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- Johns Hopkins Hospital, Baltimore
Menerima pesertaFase 3
Usia 0 hingga 17 · Semua jenis kelamin · Diperbarui 17 Jul 2025 · NCT05261139Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- All Natural Medicine Clinic, LLC, Rockville
Menerima pesertaFase 1/2
Semua usia · Semua jenis kelamin · Diperbarui 19 Feb 2025 · NCT04790240Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
- NIH Clinical Center, Bethesda
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT06441955Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.